Bentham Science Logo

Track Your Manuscript:


Infectious Disorders - Drug Targets

Formerly: Current Drug Targets - Infectious Disorders

Volume 21, 8 Issues, 2021
ISSN: 2212-3989 (Online)
ISSN: 1871-5265 (Print)
This journal supports open access

Most Cited Articles


Editorial

Counter-regulatory ‘renin-angiotensin’ system-based candidate drugs to treat COVID-19 diseases in SARS-CoV-2-infected patients

, 2020; 20(4): 407-408.

Cédric ANNWEILER, Zhijian CAO, Yingliang WU, Emmanuelle FAUCON, Stéphanie MOUHAT, Hervé KOVACIC and Jean-Marc SABATIER


DOI: 10.2174/1871526520666200518073329


Case Report

A patient with COVID-19 disease in a referral hospital in Iran: A typical case

, 2020; 20(4): 559-562.

Fereshteh Ghiasvand, Sepideh Zahak Miandoab, Hamid Harandi, Fereshteh Shahmari Golestan and Seyed Ahmad Seyed Alinaghi*


DOI: 10.2174/1871526520666200429115535




Research Article

Sofosbuvir, pegylated interferon and ribavirin in the treatment of an Egyptian cohort with hepatitis C virus infection in real-life clinical practice

, 2019; 19(2): 179-184.

Sherief Abd-Elsalam*, Rehab Badawi, Sally Elnawasany, Mohamed Yousef, Loai Mansour, Nehad Hawash, Reham A. Elkhouly, Shaimaa Soliman, Amal Selim, Abdelrahman Kobtan and Asem Elfert


DOI: 10.2174/1871526518666180912121835


Review Article

PZQ therapy: How close are we in the development of effective alternative anti-schistosomal drugs?

, 2019; 19(4): 337-349.

Raphael Taiwo Aruleba*, Tayo Alex Adekiya, Babatunji Emmanuel Oyinloye, Priscilla Masamba, Londiwe Simphiwe Mbatha, Ashley Pretorius and Abidemi Paul Kappo


DOI: 10.2174/1871526519666181231153139


Systematic Review Article

Hand hygiene compliance and effectiveness against respiratory infections among hajj pilgrims: A systematic review

, 2020; 20(3): 273-283.

Amani S. Alqahtani, Mutaz Fakeerh, Daniah Bondagji, Silvia Park, Anita E. Heywood, Kerrie E. Wiley, Robert Booy and Harunor Rashid*


DOI: 10.2174/1871526518666181001145041


Research Article

Synthesis, biological evaluation and molecular docking studies of new pyrazolines as an antitubercular and cytotoxic agents

, 2019; 19(3): 310-321.

Bontha Venkata Subrahmanya Lokesh*, Y. Rajendra Prasad and Afzal Basha Shaik


DOI: 10.2174/1871526519666181217120626


Review Article

Hepatitis C virus: Efficacy of new daas regimens

, 2020; 20(2): 143-149.

Amal Ahmed Mohamed, Naglaa El-Toukhy Ramadan El-Toukhy, Ebada Mohamed Said, Hoda Mohamed Rabie Gabal, Hossameldin AbdelAziz, Wahid Doss, Hadeel El-Hanafi, Hala H. El Deeb, Seham Mahmoud, Mahmoud Elkadeem, Hassan Salama Shalby and Sherief Abd-Elsalam*


DOI: 10.2174/1871526519666190121114003


Review Article

Albendazole and treatment of hydatid cyst: Review of the literature

, 2019; 19(2): 101-104.

Azar B. Dehkordi, Behnam Sanei, Morteza Yousefi, Seyedeh M. Sharafi, Farhang Safarnezhad, Rasool Jafari and Hossein Y. Darani*


DOI: 10.2174/1871526518666180629134511







Editor-in-Chief

Jean-Marc Sabatier
Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE, Cedex 20
(France)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets - Infectious Disorders was launched in 2001 and later renamed in 2006 as Infectious Disorders - Drug Targets.
New eBook

Frontiers in Clinical Drug Research-Anti Infectives



You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog